Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)

References

• AlcocerL2003Statins for everybody? New evidence on the efficacy and safety of the inhibitors of HMG Co-A reductaseAm J Ther10423814624280
   PubMedGoogle Scholar
• Alvarez de SotomayorMAndriantsitohainaR2001Simvastatin and Ca(2+) signaling in endothelial cells: involvement of rho proteinBiochem Biophys Res Commun2804869011162544
   PubMed Web of Science ®Google Scholar
• [AREDS] Age-Related Eye Disease Study Research Group1999The Age-Related Eye Disease Study (AREDS): design implications. AREDS report no. 1Control Clin Trials2057360010588299
   PubMedGoogle Scholar
• [AREDS] Age-Related Eye Disease Study Research Group2001A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8Arch Ophthalmol11914173611594942
   PubMedGoogle Scholar
• AriyasuRLeePLintonK1996Sensitivity, specificity, and predictive values of screening tests for eye conditions in a clinic-based populationOphthalmology1031751608942866
   PubMed Web of Science ®Google Scholar
• BaileyILovieJ1976New design principles for visual acuity letter chartsAm J Optom Physiol Optics537405
   PubMedGoogle Scholar
• BairdPRichardsonARobmanL2006Apolipoprotein (APOE) gene is associated with progression of age-related macular degeneration (AMD)Hum Mutat273374216453339
   PubMed Web of Science ®Google Scholar
• BairdPNRobmanLDRichardsonAJ2008Gene-environment interaction in progression of AMD – the CFH gene, smoking and exposure to chronic infectionHum Mol Genet17129930518203751
   PubMed Web of Science ®Google Scholar
• BakerSTarnopolskyM2005Statin-associated neuromyotoxicityTimely Top Med Cardiovasc Dis9E2616215630
   PubMedGoogle Scholar
• BellostaSFerriNBerniniF2000Non-lipid-related effects of statinsAnn Med321647610821323
   PubMed Web of Science ®Google Scholar
• BirdACBresslerNMBresslerSB1995An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study GroupSurv Ophthalmol39367747604360
   PubMed Web of Science ®Google Scholar
• BrownBAdamsAColettaNJ1986Dark adaptation in age-related maculopathyOphthalmic Physiol Optics6814
   PubMed Web of Science ®Google Scholar
• ChuoJYWiensMEtminanM2007Use of lipid-lowering agents for the prevention of age-related macular degeneration: a meta-analysis of observational studiesOphthalmic Epidemiol143677418161610
   PubMed Web of Science ®Google Scholar
• CurcioCAMedeirosNEMillicanCL1996Photoreceptor loss in age-related macular degenerationInvest Ophthalmol Vis Sci371236498641827
   PubMed Web of Science ®Google Scholar
• DelcourtCMichelFColvezA2001Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA studyOphthalmic Epidemiol82374911471092
   PubMedGoogle Scholar
• DemirelSVingrysAJ1994Eye movements during perimetry and the effect that fixational instability has on perimetric outcomesJ Glaucoma32835
   Google Scholar
• DimitrovPNGuymerRHZeleAJ2008Measuring rod and cone dynamics in age-related maculopathyInvest Ophthalmol Vis Sci49556518172075
   PubMed Web of Science ®Google Scholar
• EdwardsAORitterR3rdAbelKJ2005Complement factor H polymorphism and age-related macular degenerationScience308421415761121
   PubMed Web of Science ®Google Scholar
• FriedmanERigasIKMakarM2005The relationship of statin use to the development of age-related macular degeneration [abstract]Invest Ophthalmol Vis Sci ARVO46199
   Web of Science ®Google Scholar
• FriedmanE2004Update of the vascular model of AMDBr J Ophthalmol88161314736760
   PubMed Web of Science ®Google Scholar
• GunkelRGourasP1963Changes in scotopic visibility threshold with ageArch Ophthalmol694913951273
   PubMedGoogle Scholar
• GuymerRLuthertPBirdA1999Changes in Bruch’s membrane and related structures with ageProg Ret Eye Res185990
   PubMed Web of Science ®Google Scholar
• HagemanGSAndersonDHJohnsonLV2005A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degenerationProc Natl Acad Sci U S A10272273215870199
   PubMed Web of Science ®Google Scholar
• HagemanGSLuthertPJVictor ChongNH2001An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degenerationProg Retin Eye Res207053211587915
   PubMed Web of Science ®Google Scholar
• HaimoviciRGantzDLRumeltS2001The lipid composition of drusen, Bruch’s membrane, and sclera by hot stage polarizing light microscopyInvest Ophthalmol Vis Sci421592911381066
   PubMed Web of Science ®Google Scholar
• HainesJLHauserMASchmidtS2005Complement factor H variant increases the risk of age-related macular degenerationScience3084192115761120
   PubMed Web of Science ®Google Scholar
• HallNFGaleCRSyddallH2001Risk of macular degeneration in users of statins: cross sectional studyBMJ323375611509429
   PubMed Web of Science ®Google Scholar
• HanleyJMHaugenTHeathE1983Biosynthesis and processing of rat haptoglobinJ Biol Chem2587858696863267
   PubMed Web of Science ®Google Scholar
• HassellJBWeihLMKeeffeJE2000A measure of handicap for low vision rehabilitation: the impact of vision impairment profileClin Exp Ophthalmol2815661
   PubMed Web of Science ®Google Scholar
• HessDFaganS2001Pharmacology and clinical experience with simvastatinExpert Opin Pharmacother21536311336576
   PubMedGoogle Scholar
• HunninghakeDBKnoppRHSchonfeldG1990Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response studyAtherosclerosis858192126437
   PubMed Web of Science ®Google Scholar
• InoueIGotoSMizotaniK2000Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cellsLife Sciences678637610946846
   PubMed Web of Science ®Google Scholar
• JialalISteinDBalisD2001Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levelsCirculation1031933511306519
   PubMed Web of Science ®Google Scholar
• JonesPKafonekSLauroraI1998Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)Am J Cardiol8158279514454
   PubMed Web of Science ®Google Scholar
• KeeffeJMcCartyCHassellJ1999Description and measurement of handicap caused by vision impairmentAust N Z J Ophthalmol27184610484186
   PubMedGoogle Scholar
• KleinRDengYKleinBE2007aCardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women’s Health Initiative Sight Exam ancillary studyAm J Ophthalmol1434738317317391
   PubMed Web of Science ®Google Scholar
• KleinRKleinBE2004Do statins prevent age-related macular degeneration?Am J Ophthalmol137747915059716
   PubMed Web of Science ®Google Scholar
• KleinRKleinBETomanySC2003aThe association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye StudyOphthalmology1106364312689879
   PubMed Web of Science ®Google Scholar
• KleinRKleinBETomanySC2003bRelation of statin use to the 5-year incidence and progression of age-related maculopathyArch Ophthalmol1211151512912693
   PubMed Web of Science ®Google Scholar
• KleinRKnudtsonMDKleinBE2007bStatin use and the five-year incidence and progression of age-related macular degenerationAm J Ophthalmol1441617475196
   PubMed Web of Science ®Google Scholar
• KleinRJZeissCChewEY2005Complement factor H polymorphism in age-related macular degenerationScience308385915761122
   PubMed Web of Science ®Google Scholar
• KuvinJTKarasRH2003The effects of LDL reduction and HDL augmentation on physiologic and inflammatory markersCurr Opin Cardiol1829530012858128
   PubMed Web of Science ®Google Scholar
• KwakBMulhauptFVeillardN2001The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cellsSwiss Med Wkly13141611219190
   PubMed Web of Science ®Google Scholar
• LambT1981The involvement of rod photoreceptors in dark adaptationVision Res211773827336615
   PubMed Web of Science ®Google Scholar
• LambTPughEJr2004Dark adaptation and the retinoid cycle of visionProg Ret Eye Res2330780
   PubMed Web of Science ®Google Scholar
• LampertiCNainiALucchiniV2005Muscle coenzyme Q10 level in statin-related myopathyArch Neurol6217091216286544
   PubMed Web of Science ®Google Scholar
• LudvighEMcCarthyE1938Absorption of the visible light by the refractive media of the human eyeArch Ophthalmol2037
   Google Scholar
• [MPSG] Macular Photocoagulation Study Group1991Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study GroupArch Ophthalmol1091220311718250
   PubMedGoogle Scholar
• McCartyCAMukeshBNFuCL2001aRisk factors for age-related maculopathy: the Visual Impairment ProjectArch Ophthalmol11914556211594944
   PubMed Web of Science ®Google Scholar
• McCartyCAMukeshBNGuymerRH2001bCholesterol-lowering medications reduce the risk of age-related maculopathy progressionMJA17517
   Web of Science ®Google Scholar
• McGwinGJrModjarradKHallTA20063-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health StudyArch Ophthalmol12433716401782
   PubMedGoogle Scholar
• McGwinGJrOwsleyCCurcioCA2003The association between statin use and age related maculopathyBr J Ophthalmol871121512928279
   PubMed Web of Science ®Google Scholar
• McGwinGJrXieAOwsleyC2005The use of cholesterol-lowering medications and age-related macular degenerationOphthalmology1124889415745779
   PubMed Web of Science ®Google Scholar
• MethaABVingrysAJBadcockDR1993Calibration of a colour monitor for visual psychophysicsBeh Res Meth Instrum Comp2537183
   Google Scholar
• MitchellPSmithWAtteboK1995Prevalence of age-related maculopathy in AustraliaOphthalmology1021450609097791
   PubMed Web of Science ®Google Scholar
• [NHFA] National Heart Foundation of Australia, Cardiac Society of Australia and New Zealand2001Lipid management guidelines 2001Med J Aust175SupplS57S8511758552
   PubMedGoogle Scholar
• OwsleyCJacksonGWhiteM2001Delays in rod-mediated dark adaptation in early age-related maculopathyOphthalmology108119620211425675
   PubMed Web of Science ®Google Scholar
• OwsleyCJacksonGRCideciyanAV2000Psychophysical evidence for rod vulnerability in age-related macular degenerationInvest Ophthalmol Vis Sci412677310634630
   PubMed Web of Science ®Google Scholar
• PhippsJAGuymerRHVingrysAJ2003Loss of cone function in age-related maculopathyInvest Ophthalmol Vis Sci4422778312714671
   PubMed Web of Science ®Google Scholar
• PrueferDScaliaRLeferAM1999Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic ratsArterioscler Thromb Vasc Biol19289490010591666
   PubMed Web of Science ®Google Scholar
• RobmanLMcNeilJDimitrovP2004Methodology of the Cardiovascular Health and Age-Related Maculopathy (CHARM) StudyOphthalmic Epidemiol111617915370549
   PubMed Web of Science ®Google Scholar
• RothmanKGreenlandS1998Modern EpidemiologyPhiladelphia, PALipcott Williams and Wilkins
   Google Scholar
• SackettCSSchenningS2002The age-related eye disease study: the results of the clinical trialInsight275711962062
   PubMedGoogle Scholar
• SaidFWealeR1959The variation with age of the spectral transmissivity of the living human crystalline lensGerontologia32133114440799
   PubMedGoogle Scholar
• SmeethLCookCChakravarthyU2005A case control study of age related macular degeneration and use of statinsBr J Ophthalmol891171516113375
   PubMed Web of Science ®Google Scholar
• SmithWAssinkJKleinR2001Risk factors for age-related macular degeneration: Pooled findings from three continentsOphthalmology10869770411297486
   PubMed Web of Science ®Google Scholar
• SpaideRFHo-SpaideWCBrowneRW1999Characterization of peroxidized lipids in Bruch’s membraneRetina19141710213241
   PubMed Web of Science ®Google Scholar
• SunnessJSMassofRWJohnsonMA1989Diminished foveal sensitivity may predict the development of advanced age-related macular degenerationOphthalmology96375812710529
   PubMed Web of Science ®Google Scholar
• TakemotoMLiaoJK2001Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitorsArterioscler Thromb Vasc Biol211712911701455
   PubMed Web of Science ®Google Scholar
• TanJSMitchellPRochtchinaE2007Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye StudyAm J Ophthalmol143685717386278
   PubMed Web of Science ®Google Scholar
• TaylorHWestS1988A simple system for the clinical grading of lens opacitiesLens Res517581
   Google Scholar
• TaylorHR2002Fred Hollows lecture. Eye care for the communityClin Exp Ophthalmol301514
   Web of Science ®Google Scholar
• TaylorHRTikellisGRobmanLD2002Vitamin E supplementation and macular degeneration: randomised controlled trialBMJ3251112098721
   PubMed Web of Science ®Google Scholar
• TikellisGRobmanLDDimitrovP2007Characteristics of progression of early age-related macular degeneration: the Cardiovascular Health and Age-Related Maculopathy StudyEye211697616732219
   PubMed Web of Science ®Google Scholar
• van LeeuwenRKlaverCCVingerlingJR2004aCholesterol and age-related macular degeneration: is there a link?Am J Ophthalmol137750215059717
   PubMed Web of Science ®Google Scholar
• van LeeuwenRTomanySCWangJJ2004bIs medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continentsOphthalmology11111697515177967
   PubMed Web of Science ®Google Scholar
• van LeeuwenRVingerlingJRHofmanA2003Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurementBMJ326255612560276
   PubMed Web of Science ®Google Scholar
• Van NewkirkMNanjanMWangJ2000The prevalence of age-related maculopathy: the Visual Impairment ProjectOphthalmology107159360010919916
   PubMed Web of Science ®Google Scholar
• WattsG2001Treating patients with low high-density lipoprotein cholesterol: choices, issues and opportunitiesCurr Control Trials Cardiovasc Med21182211806784
   PubMedGoogle Scholar
• WilsonHLSchwartzDMBhattHR2004Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degenerationAm J Ophthalmol1376152415059698
   PubMed Web of Science ®Google Scholar
• ZeleAVingrysA2005Cathode-ray-tube monitor artefacts in neurophysiologyJ Neurosci Methods1411715585283
   PubMed Web of Science ®Google Scholar